| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.60e-08 | 35 | 46 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 8.54e-06 | 211 | 46 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 1.56e-05 | 3 | 46 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.63e-05 | 153 | 46 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 4.93e-05 | 288 | 46 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 5.17e-05 | 5 | 46 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.64e-04 | 14 | 46 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.74e-04 | 614 | 46 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.97e-04 | 441 | 46 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 7.71e-04 | 78 | 46 | 3 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 8.30e-04 | 80 | 46 | 3 | GO:0008186 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.85e-03 | 775 | 46 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 1.89e-03 | 28 | 46 | 2 | GO:0001972 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.54e-03 | 118 | 46 | 3 | GO:0003774 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 2.63e-03 | 417 | 46 | 5 | GO:0140098 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 2.89e-03 | 839 | 46 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 2.90e-03 | 840 | 46 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 2.90e-03 | 840 | 46 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.04e-03 | 46 | 46 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | retinoid binding | 5.47e-03 | 48 | 46 | 2 | GO:0005501 | |
| GeneOntologyMolecularFunction | ADP binding | 5.47e-03 | 48 | 46 | 2 | GO:0043531 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 5.70e-03 | 49 | 46 | 2 | GO:0019840 | |
| GeneOntologyMolecularFunction | helicase activity | 5.75e-03 | 158 | 46 | 3 | GO:0004386 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 1.51e-09 | 8 | 46 | 4 | GO:0070980 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 4.50e-09 | 10 | 46 | 4 | GO:0018879 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.06e-08 | 12 | 46 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.26e-07 | 21 | 46 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 3.12e-07 | 26 | 46 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 3.12e-07 | 26 | 46 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.35e-06 | 37 | 46 | 4 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.35e-06 | 37 | 46 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 1.51e-06 | 38 | 46 | 4 | GO:0008209 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 5.42e-06 | 52 | 46 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | membrane depolarization during atrial cardiac muscle cell action potential | 1.46e-05 | 3 | 46 | 2 | GO:0098912 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 4.85e-05 | 5 | 46 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 7.26e-05 | 6 | 46 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.32e-04 | 222 | 46 | 5 | GO:0071466 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.73e-04 | 141 | 46 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 3.17e-04 | 12 | 46 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 3.17e-04 | 12 | 46 | 2 | GO:0086016 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.73e-04 | 153 | 46 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 4.26e-04 | 286 | 46 | 5 | GO:0042445 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 5.02e-04 | 15 | 46 | 2 | GO:0086067 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 6.06e-04 | 174 | 46 | 4 | GO:1904064 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 7.43e-04 | 684 | 46 | 7 | GO:0010817 | |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | 7.50e-04 | 324 | 46 | 5 | GO:0072659 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell communication | 8.12e-04 | 19 | 46 | 2 | GO:0086066 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell signaling | 8.12e-04 | 19 | 46 | 2 | GO:0086026 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell action potential | 8.12e-04 | 19 | 46 | 2 | GO:0086014 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 8.75e-04 | 192 | 46 | 4 | GO:0034767 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate biosynthetic process | 9.01e-04 | 20 | 46 | 2 | GO:0030206 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 9.65e-04 | 87 | 46 | 3 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.09e-03 | 22 | 46 | 2 | GO:1902514 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.17e-03 | 93 | 46 | 3 | GO:0086003 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 1.19e-03 | 23 | 46 | 2 | GO:0086012 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 1.19e-03 | 23 | 46 | 2 | GO:0061577 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.77e-06 | 40 | 46 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | CA3 pyramidal cell dendrite | 1.42e-05 | 3 | 46 | 2 | GO:0097442 | |
| GeneOntologyCellularComponent | NLRP3 inflammasome complex | 1.32e-04 | 8 | 46 | 2 | GO:0072559 | |
| GeneOntologyCellularComponent | basal dendrite | 2.11e-04 | 10 | 46 | 2 | GO:0097441 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 3.08e-04 | 12 | 46 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | organelle outer membrane | 3.58e-04 | 279 | 46 | 5 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 3.70e-04 | 281 | 46 | 5 | GO:0019867 | |
| GeneOntologyCellularComponent | T-tubule | 7.01e-04 | 79 | 46 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | canonical inflammasome complex | 7.09e-04 | 18 | 46 | 2 | GO:0061702 | |
| GeneOntologyCellularComponent | sarcolemma | 8.01e-04 | 190 | 46 | 4 | GO:0042383 | |
| GeneOntologyCellularComponent | apical dendrite | 2.25e-03 | 32 | 46 | 2 | GO:0097440 | |
| Domain | UDPGT | 1.28e-09 | 21 | 45 | 5 | PS00375 | |
| Domain | UDPGT | 1.28e-09 | 21 | 45 | 5 | PF00201 | |
| Domain | UDP_glucos_trans | 1.28e-09 | 21 | 45 | 5 | IPR002213 | |
| Domain | P-loop_NTPase | 1.60e-04 | 848 | 45 | 9 | IPR027417 | |
| Domain | DEAD | 7.23e-04 | 73 | 45 | 3 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 7.23e-04 | 73 | 45 | 3 | IPR011545 | |
| Domain | DUF1605 | 7.54e-04 | 17 | 45 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 7.54e-04 | 17 | 45 | 2 | PF07717 | |
| Domain | HA2 | 8.47e-04 | 18 | 45 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 8.47e-04 | 18 | 45 | 2 | IPR007502 | |
| Domain | HA2 | 8.47e-04 | 18 | 45 | 2 | SM00847 | |
| Domain | - | 1.90e-03 | 746 | 45 | 7 | 3.40.50.300 | |
| Domain | Helicase_C | 2.18e-03 | 107 | 45 | 3 | PF00271 | |
| Domain | HELICc | 2.18e-03 | 107 | 45 | 3 | SM00490 | |
| Domain | Helicase_C | 2.24e-03 | 108 | 45 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 2.30e-03 | 109 | 45 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.30e-03 | 109 | 45 | 3 | PS51192 | |
| Domain | DEXDc | 2.30e-03 | 109 | 45 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.36e-03 | 110 | 45 | 3 | IPR014001 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.21e-03 | 35 | 45 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 3.78e-03 | 38 | 45 | 2 | PS00690 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.09e-11 | 24 | 32 | 6 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.43e-11 | 25 | 32 | 6 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 2.24e-09 | 25 | 32 | 5 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.24e-09 | 25 | 32 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 2.76e-09 | 26 | 32 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 4.11e-09 | 28 | 32 | 5 | M19580 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.43e-08 | 44 | 32 | 5 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.98e-08 | 45 | 32 | 5 | MM15694 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.05e-07 | 52 | 32 | 5 | M14171 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.28e-07 | 107 | 32 | 6 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.43e-07 | 109 | 32 | 6 | M18788 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.88e-07 | 23 | 32 | 4 | MM16639 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.70e-06 | 39 | 32 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.09e-06 | 41 | 32 | 4 | M7399 | |
| Pathway | REACTOME_DRUG_ADME | 4.30e-06 | 109 | 32 | 5 | M45012 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 5.07e-06 | 51 | 32 | 4 | M17726 | |
| Pathway | REACTOME_DRUG_ADME | 6.61e-06 | 119 | 32 | 5 | MM15692 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 6.88e-06 | 55 | 32 | 4 | M14933 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 8.49e-06 | 219 | 32 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 8.71e-06 | 220 | 32 | 6 | M10320 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.26e-05 | 64 | 32 | 4 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.80e-05 | 70 | 32 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.02e-05 | 72 | 32 | 4 | M9257 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 5.04e-05 | 32 | 32 | 3 | M27455 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 5.29e-05 | 183 | 32 | 5 | M39588 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.39e-04 | 8 | 32 | 2 | MM15197 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 4.47e-04 | 14 | 32 | 2 | M39328 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 4.47e-04 | 14 | 32 | 2 | MM15198 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 5.15e-04 | 15 | 32 | 2 | M27456 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 1.02e-03 | 21 | 32 | 2 | M47950 | |
| Pathway | WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY | 1.34e-03 | 24 | 32 | 2 | M39399 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.45e-03 | 25 | 32 | 2 | M47948 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 1.82e-03 | 28 | 32 | 2 | M10679 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.85e-03 | 108 | 32 | 3 | M17034 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.13e-03 | 130 | 32 | 3 | M27454 | |
| Pubmed | 1.02e-10 | 7 | 47 | 4 | 26074487 | ||
| Pubmed | 2.04e-10 | 8 | 47 | 4 | 32093886 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.17e-07 | 497 | 47 | 8 | 36774506 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19261907 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 10222050 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 34072954 | ||
| Pubmed | The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome. | 1.79e-06 | 2 | 47 | 2 | 23871209 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17263731 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21679149 | ||
| Pubmed | Ahnak is critical for cardiac Ca(V)1.2 calcium channel function and its beta-adrenergic regulation. | 1.79e-06 | 2 | 47 | 2 | 16319140 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15319348 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15339916 | ||
| Pubmed | Ahnak1 interaction is affected by phosphorylation of Ser-296 on Cavβ₂. | 1.79e-06 | 2 | 47 | 2 | 22497893 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 14674701 | ||
| Pubmed | 1.98e-06 | 66 | 47 | 4 | 19898482 | ||
| Pubmed | 4.16e-06 | 177 | 47 | 5 | 26206133 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 11171103 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 20817017 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25107449 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 7835904 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 19106618 | ||
| Pubmed | USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. | 5.36e-06 | 3 | 47 | 2 | 30206189 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 8333863 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 29138287 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 17224476 | ||
| Pubmed | Requirement of the Ca2+ channel β2 subunit for sympathetic PKA phosphorylation. | 5.36e-06 | 3 | 47 | 2 | 33602505 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 18165320 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 22092298 | ||
| Pubmed | Calmodulin-dependent gating of Ca(v)1.2 calcium channels in the absence of Ca(v)beta subunits. | 1.07e-05 | 4 | 47 | 2 | 18535142 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 16849011 | ||
| Pubmed | Regional expression of L-type calcium channel subunits during cardiac development. | 1.07e-05 | 4 | 47 | 2 | 15108317 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 19723630 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 15318931 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 16787652 | ||
| Pubmed | Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins. | 1.78e-05 | 5 | 47 | 2 | 19564422 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 21224388 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 20056642 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 18052087 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 10748067 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 25172487 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 18719240 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 20142249 | ||
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 5.52e-05 | 303 | 47 | 5 | 25056061 | |
| Pubmed | Functional skewing of TRIM21-SIRT5 interplay dictates IL-1β production in DSS-induced colitis. | 6.40e-05 | 9 | 47 | 2 | 35770730 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 22726441 | ||
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 18809727 | ||
| Pubmed | Transient microglial absence assists postmigratory cortical neurons in proper differentiation. | 9.75e-05 | 11 | 47 | 2 | 32242005 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.17e-04 | 12 | 47 | 2 | 20308471 | |
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 18161889 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 1.24e-04 | 1455 | 47 | 9 | 22863883 | |
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 1.61e-04 | 14 | 47 | 2 | 29107716 | |
| Pubmed | 1.86e-04 | 15 | 47 | 2 | 20188150 | ||
| Pubmed | 1.86e-04 | 15 | 47 | 2 | 24453333 | ||
| Pubmed | 2.11e-04 | 85 | 47 | 3 | 23055939 | ||
| Pubmed | 2.70e-04 | 18 | 47 | 2 | 19640993 | ||
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 2.70e-04 | 18 | 47 | 2 | 25363768 | |
| Pubmed | 2.70e-04 | 18 | 47 | 2 | 20056724 | ||
| Pubmed | 2.84e-04 | 234 | 47 | 4 | 36243803 | ||
| Pubmed | Identification of novel ARF binding proteins by two-hybrid screening. | 3.69e-04 | 21 | 47 | 2 | 16582619 | |
| Pubmed | 4.06e-04 | 22 | 47 | 2 | 36877136 | ||
| Pubmed | Gene-environment interaction impacts on heart development and embryo survival. | 4.06e-04 | 22 | 47 | 2 | 30787001 | |
| Pubmed | 4.20e-04 | 469 | 47 | 5 | 27634302 | ||
| Pubmed | Genome-wide association analysis identifies 13 new risk loci for schizophrenia. | 4.39e-04 | 109 | 47 | 3 | 23974872 | |
| Pubmed | 4.84e-04 | 24 | 47 | 2 | 20301690 | ||
| Pubmed | 5.41e-04 | 496 | 47 | 5 | 31343991 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 6.65e-04 | 1105 | 47 | 7 | 35748872 | |
| Pubmed | 7.41e-04 | 809 | 47 | 6 | 32129710 | ||
| Pubmed | Single-cell transcriptomic landscapes of the otic neuronal lineage at multiple early embryonic ages. | 7.59e-04 | 30 | 47 | 2 | 35320729 | |
| Pubmed | 8.55e-04 | 549 | 47 | 5 | 38280479 | ||
| Pubmed | Maternal diabetes alters transcriptional programs in the developing embryo. | 8.64e-04 | 32 | 47 | 2 | 19538749 | |
| Pubmed | 9.19e-04 | 33 | 47 | 2 | 24705356 | ||
| Pubmed | 9.19e-04 | 33 | 47 | 2 | 30037926 | ||
| Pubmed | 1.03e-03 | 35 | 47 | 2 | 23969696 | ||
| Pubmed | 1.16e-03 | 37 | 47 | 2 | 34147029 | ||
| Pubmed | 1.22e-03 | 38 | 47 | 2 | 20214802 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.22e-03 | 38 | 47 | 2 | 30786075 | |
| Pubmed | 1.24e-03 | 347 | 47 | 4 | 17114649 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.09e-05 | 157 | 47 | 4 | chr4q13 | |
| Cytoband | 4q13 | 1.07e-04 | 15 | 47 | 2 | 4q13 | |
| Cytoband | 4q13.2 | 4.68e-04 | 31 | 47 | 2 | 4q13.2 | |
| GeneFamily | UDP glucuronosyltransferases | 3.91e-09 | 32 | 35 | 5 | 363 | |
| GeneFamily | DEAH-box helicases | 4.29e-04 | 16 | 35 | 2 | 500 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.15e-03 | 26 | 35 | 2 | 253 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.43e-03 | 29 | 35 | 2 | 396 | |
| Coexpression | WENG_POR_TARGETS_LIVER_UP | 3.59e-08 | 53 | 46 | 5 | MM1203 | |
| Coexpression | TERAMOTO_OPN_TARGETS_CLUSTER_7 | 4.05e-06 | 18 | 46 | 3 | M1203 | |
| Coexpression | TERAMOTO_OPN_TARGETS_CLUSTER_7 | 4.81e-06 | 19 | 46 | 3 | MM524 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 1.58e-05 | 180 | 46 | 5 | M6878 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 2.04e-05 | 190 | 46 | 5 | MM1311 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 2.33e-05 | 330 | 46 | 6 | MM1120 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN | 2.55e-05 | 199 | 46 | 5 | M9031 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP | 2.62e-05 | 200 | 46 | 5 | M4584 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 2.68e-05 | 201 | 46 | 5 | MM1294 | |
| Coexpression | VANLOO_SP3_TARGETS_DN | 3.23e-05 | 103 | 46 | 4 | MM919 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 6.07e-05 | 121 | 46 | 4 | MM935 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 1.03e-04 | 267 | 46 | 5 | MM984 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | 1.59e-04 | 467 | 46 | 6 | MM1233 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.92e-07 | 162 | 46 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-06 | 185 | 46 | 5 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.69e-06 | 122 | 46 | 4 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 165 | 46 | 4 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 172 | 46 | 4 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 172 | 46 | 4 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 173 | 46 | 4 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.86e-05 | 184 | 46 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-05 | 185 | 46 | 4 | 5dee5645240637e135677732a35fd416b37367d4 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.20e-05 | 188 | 46 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.20e-05 | 188 | 46 | 4 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 189 | 46 | 4 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 189 | 46 | 4 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.29e-05 | 189 | 46 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 189 | 46 | 4 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 189 | 46 | 4 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.38e-05 | 190 | 46 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-05 | 190 | 46 | 4 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 191 | 46 | 4 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 191 | 46 | 4 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 193 | 46 | 4 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 193 | 46 | 4 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-05 | 194 | 46 | 4 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.84e-05 | 195 | 46 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.04e-05 | 197 | 46 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4|Liver / Manually curated celltypes from each tissue | 5.04e-05 | 197 | 46 | 4 | 4891111894b741555f549deec6af8006376d9358 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| Drug | AC1NOWCJ | 8.35e-09 | 35 | 46 | 5 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 8.35e-09 | 35 | 46 | 5 | CID010436171 | |
| Drug | testosterone glucuronide | 1.91e-08 | 41 | 46 | 5 | CID000108192 | |
| Drug | C1 11-32 | 4.37e-08 | 18 | 46 | 4 | CID000443077 | |
| Drug | C11131 | 4.37e-08 | 18 | 46 | 4 | CID000443076 | |
| Drug | T4-G | 5.53e-08 | 19 | 46 | 4 | CID000152424 | |
| Drug | AC1NQGK1 | 6.51e-08 | 52 | 46 | 5 | CID005195977 | |
| Drug | estriol-16-glucuronide | 8.51e-08 | 21 | 46 | 4 | CID000122281 | |
| Drug | 4-hydroxybiphenyl | 1.24e-07 | 59 | 46 | 5 | CID000007103 | |
| Drug | estradiol-3-glucuronide | 1.26e-07 | 23 | 46 | 4 | CID000066651 | |
| Drug | fibrates | 1.35e-07 | 118 | 46 | 6 | CID000002797 | |
| Drug | UDP-alpha-d-xylopyranose | 1.35e-07 | 60 | 46 | 5 | CID000001165 | |
| Drug | 3-OHBaP | 1.73e-07 | 63 | 46 | 5 | CID000025890 | |
| Drug | L-idaro-1,4-lactone | 2.88e-07 | 28 | 46 | 4 | CID000078997 | |
| Drug | 7-hydroxycoumarin glucuronide | 3.34e-07 | 29 | 46 | 4 | CID000125641 | |
| Drug | eugenol | 3.65e-07 | 73 | 46 | 5 | CID000003314 | |
| Drug | 7-hydroxycoumarin | 4.18e-07 | 75 | 46 | 5 | CID005281426 | |
| Drug | AC1N8H7N | 5.09e-07 | 78 | 46 | 5 | CID004318740 | |
| Drug | AC1Q6OQG | 5.72e-07 | 33 | 46 | 4 | CID000009686 | |
| Drug | BP-3,6-quinol | 5.72e-07 | 33 | 46 | 4 | CID000119292 | |
| Drug | estrone-3-glucuronide | 7.29e-07 | 35 | 46 | 4 | CID000115255 | |
| Drug | menthol | 8.79e-07 | 87 | 46 | 5 | CID000001254 | |
| Drug | l-borneol | 9.17e-07 | 37 | 46 | 4 | CID000010049 | |
| Drug | glucosiduronate | 1.20e-06 | 171 | 46 | 6 | CID000000610 | |
| Drug | harmol | 1.26e-06 | 40 | 46 | 4 | CID000068094 | |
| Drug | Biliton | 1.40e-06 | 41 | 46 | 4 | CID000002974 | |
| Drug | 2-AF | 1.40e-06 | 41 | 46 | 4 | CID000005800 | |
| Drug | 1-naphthol | 1.59e-06 | 98 | 46 | 5 | CID000007005 | |
| Drug | androsterone glucuronide | 1.70e-06 | 43 | 46 | 4 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 1.70e-06 | 43 | 46 | 4 | CID000009191 | |
| Drug | MS-222 | 1.87e-06 | 44 | 46 | 4 | CID000011400 | |
| Drug | uridine 5'-diphosphoglucuronic acid | 2.15e-06 | 189 | 46 | 6 | CID000000390 | |
| Drug | salicylamide | 2.66e-06 | 48 | 46 | 4 | CID000005147 | |
| Drug | oxazepam | 3.97e-06 | 53 | 46 | 4 | CID000004616 | |
| Drug | 2-hydroxyestriol | 3.99e-06 | 2 | 46 | 2 | ctd:C008012 | |
| Drug | 7-methoxycoumarin | 5.33e-06 | 57 | 46 | 4 | CID000010748 | |
| Drug | phenolphthalein | 5.71e-06 | 58 | 46 | 4 | CID000004764 | |
| Drug | urochloralic acid | 6.12e-06 | 59 | 46 | 4 | CID003036914 | |
| Drug | 4-hydroxyestrone | 6.12e-06 | 59 | 46 | 4 | CID000018418 | |
| Drug | acetaminophen glucuronide | 6.12e-06 | 59 | 46 | 4 | CID000083944 | |
| Drug | SN-38G | 6.12e-06 | 59 | 46 | 4 | CID000443154 | |
| Drug | 4-methylumbelliferone | 6.88e-06 | 132 | 46 | 5 | CID003364573 | |
| Drug | UDP - Na | 7.52e-06 | 235 | 46 | 6 | CID000001158 | |
| Drug | aniline | 9.81e-06 | 142 | 46 | 5 | CID000006115 | |
| Drug | Meldola | 1.08e-05 | 68 | 46 | 4 | CID000081507 | |
| Drug | methoxyresorufin | 1.15e-05 | 69 | 46 | 4 | CID000119220 | |
| Drug | 5 alpha-dihydroaldosterone | 1.20e-05 | 3 | 46 | 2 | CID003036614 | |
| Drug | 2,2,2-trichloroethanol | 1.43e-05 | 73 | 46 | 4 | CID000008259 | |
| Drug | Hymecromone | 1.72e-05 | 25 | 46 | 3 | ctd:D006923 | |
| Drug | 16-epiestriol | 1.77e-05 | 77 | 46 | 4 | CID000003269 | |
| Drug | AC1LCF1F | 1.80e-05 | 161 | 46 | 5 | CID000627275 | |
| Drug | AC1L1BH2 | 1.86e-05 | 78 | 46 | 4 | CID000001436 | |
| Drug | benzyloxyresorufin | 1.86e-05 | 78 | 46 | 4 | CID000114982 | |
| Drug | acridine | 2.16e-05 | 81 | 46 | 4 | CID000009215 | |
| Drug | pheophytin | 2.20e-05 | 284 | 46 | 6 | CID000000250 | |
| Drug | NSC-686960 | 2.39e-05 | 4 | 46 | 2 | CID000192816 | |
| Drug | aminopyrine | 2.41e-05 | 171 | 46 | 5 | CID000006009 | |
| Drug | 5 alpha-androstane | 2.50e-05 | 84 | 46 | 4 | CID000094144 | |
| Drug | 7-ethoxycoumarin | 2.74e-05 | 86 | 46 | 4 | CID000035703 | |
| Drug | 4-nitrophenol | 2.84e-05 | 177 | 46 | 5 | CID000000980 | |
| Drug | pentoxyresorufin | 2.87e-05 | 87 | 46 | 4 | CID000107683 | |
| Drug | 4-aminobiphenyl | 3.58e-05 | 92 | 46 | 4 | CID000007102 | |
| Drug | p-nitroanisole | 3.58e-05 | 92 | 46 | 4 | CID000007485 | |
| Drug | clofibrate | 3.66e-05 | 311 | 46 | 6 | CID000002796 | |
| Drug | 2-naphthol | 3.73e-05 | 93 | 46 | 4 | CID000008663 | |
| Drug | Nilvadipine | 3.98e-05 | 5 | 46 | 2 | DB06712 | |
| Drug | Nisoldipine | 3.98e-05 | 5 | 46 | 2 | DB00401 | |
| Drug | hyodeoxycholic acid | 3.98e-05 | 5 | 46 | 2 | ctd:C010471 | |
| Drug | Amobarbital | 3.98e-05 | 5 | 46 | 2 | ctd:D000654 | |
| Drug | B 874-67 | 3.98e-05 | 5 | 46 | 2 | CID000195466 | |
| Drug | methyl beta-aminocrotonate | 3.98e-05 | 5 | 46 | 2 | CID000084253 | |
| Drug | phenolphthalin | 3.98e-05 | 5 | 46 | 2 | CID000066494 | |
| Drug | perfluorophenanthrene | 3.98e-05 | 5 | 46 | 2 | CID000078972 | |
| Drug | nemadipine-A | 3.98e-05 | 5 | 46 | 2 | CID002856102 | |
| Drug | DCNB | 4.06e-05 | 95 | 46 | 4 | CID000007443 | |
| Drug | ethoxyresorufin | 4.06e-05 | 95 | 46 | 4 | CID000003294 | |
| Drug | DB04103 | 4.40e-05 | 97 | 46 | 4 | CID004469987 | |
| Drug | 2-butyl-6-methoxyphenol | 4.74e-05 | 197 | 46 | 5 | CID011954184 | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 6838_DN | |
| Drug | 3-hydroxyandrostan-17-one | 5.36e-05 | 102 | 46 | 4 | CID000000225 | |
| Drug | UDP-N-acetylglucosamine | 5.46e-05 | 203 | 46 | 5 | CID000001167 | |
| Drug | 2-hydroxyestriol | 5.96e-05 | 6 | 46 | 2 | CID000014688 | |
| Drug | CPU-23 | 5.96e-05 | 6 | 46 | 2 | CID003036051 | |
| Drug | Magnesium Sulfate | 5.96e-05 | 6 | 46 | 2 | DB00653 | |
| Drug | chrysin | 6.23e-05 | 106 | 46 | 4 | CID005281607 | |
| Drug | fluconazole | 6.46e-05 | 107 | 46 | 4 | CID000003365 | |
| Drug | dioxin | 6.72e-05 | 347 | 46 | 6 | CID000015625 | |
| Drug | 2-naphthylamine | 7.20e-05 | 110 | 46 | 4 | CID000007057 | |
| Drug | arabinosyluracil | 7.51e-05 | 354 | 46 | 6 | CID000001177 | |
| Drug | benzo(a)pyrene | 7.98e-05 | 358 | 46 | 6 | CID000002336 | |
| Drug | Amlodipine | 8.33e-05 | 7 | 46 | 2 | DB00381 | |
| Drug | Isradipine | 8.33e-05 | 7 | 46 | 2 | DB00270 | |
| Drug | oxazepam glucuronide | 8.33e-05 | 7 | 46 | 2 | CID000160870 | |
| Drug | ranirestat | 8.33e-05 | 7 | 46 | 2 | ctd:C115070 | |
| Drug | lithocholic acid | 8.85e-05 | 116 | 46 | 4 | CID000009903 | |
| Drug | ethoxyquin | 8.85e-05 | 116 | 46 | 4 | CID000003293 | |
| Drug | AC1Q7AUJ | 9.15e-05 | 117 | 46 | 4 | CID000003303 | |
| Drug | alpha-naphthoflavone | 9.46e-05 | 118 | 46 | 4 | CID000011790 | |
| Drug | benzphetamine | 9.77e-05 | 119 | 46 | 4 | CID000002341 | |
| Drug | basic copper carbonate | 1.11e-04 | 8 | 46 | 2 | CID000025503 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.58e-07 | 9 | 44 | 3 | EFO_0600040 | |
| Disease | X-19141 measurement | 8.76e-07 | 13 | 44 | 3 | EFO_0800799 | |
| Disease | phosphatidylcholine 36:4 measurement | 2.49e-06 | 18 | 44 | 3 | EFO_0010382 | |
| Disease | X-24947 measurement | 4.67e-06 | 22 | 44 | 3 | EFO_0800910 | |
| Disease | vitamin D deficiency | 2.32e-05 | 37 | 44 | 3 | EFO_0003762 | |
| Disease | bipolar disorder, anorexia nervosa | 3.25e-05 | 6 | 44 | 2 | MONDO_0004985, MONDO_0005351 | |
| Disease | schizophrenia, anorexia nervosa | 5.11e-05 | 48 | 44 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | Brugada syndrome | 6.05e-05 | 8 | 44 | 2 | cv:C1142166 | |
| Disease | disease progression measurement | 1.05e-04 | 61 | 44 | 3 | EFO_0008336 | |
| Disease | Shortened QT interval | 1.19e-04 | 11 | 44 | 2 | C0151879 | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 1.21e-04 | 64 | 44 | 3 | EFO_0003888, MONDO_0005090 | |
| Disease | autism spectrum disorder, schizophrenia | 1.24e-04 | 327 | 44 | 5 | EFO_0003756, MONDO_0005090 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.65e-04 | 71 | 44 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | diverticular disease | 4.21e-04 | 236 | 44 | 4 | EFO_0009959 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 4.93e-04 | 22 | 44 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | Brugada Syndrome (disorder) | 5.87e-04 | 24 | 44 | 2 | C1142166 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 1.11e-03 | 33 | 44 | 2 | DOID:10003 (is_implicated_in) | |
| Disease | bipolar I disorder | 1.23e-03 | 141 | 44 | 3 | EFO_0009963 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKFWPKTHSPKEVMF | 366 | Q14738 | |
| KFKMPDVHFKSPQIS | 4506 | Q09666 | |
| YKAKELEDPHAKKMP | 1016 | O60231 | |
| PAVPMKDHDAIKLFV | 36 | Q96J87 | |
| PHSKEKRMPFFKKTE | 256 | Q08289 | |
| HPKTMFSKDKDIIPF | 186 | Q9UBL3 | |
| SHMFPEEEQPKKIGK | 471 | Q8IV33 | |
| TKRPPKADKEAHVMA | 1156 | Q8IY21 | |
| SKEPHNAKFPAPMDK | 2426 | Q6ZR08 | |
| KDPKEFMEHIDVPKG | 61 | Q99550 | |
| DKAVKEKIPSHHFMP | 431 | Q9HCI7 | |
| KKVGFNPKKDIHFMP | 246 | P15170 | |
| FPKKKPIEHMEDLFA | 636 | Q8NB91 | |
| FQATHPVMDLKAFPK | 421 | P40189 | |
| HLKEKAVPMPEASAF | 866 | Q13936 | |
| REFALKHLPNDPMFK | 361 | O75390 | |
| KMAAFPLEPKFAKTI | 496 | Q9H6R0 | |
| AAHFLPKPLKVAMYK | 191 | Q92913 | |
| LDKPAATVFKKEFPM | 296 | A6NC97 | |
| KDPESFFKVLMHLKD | 296 | Q4AE62 | |
| PKITTEKKNHPDFMI | 66 | Q9H2U6 | |
| LDPNFPATLFKDKMK | 56 | Q9UPX6 | |
| FFKPLMPVKEEHKKR | 1466 | Q9H1H9 | |
| DLKKFKMHLEDYPPQ | 21 | Q96P20 | |
| PLFPVVKKDMTFLHE | 1011 | Q8TEU7 | |
| FPYPEPSAKHEDKKM | 371 | Q5VWT5 | |
| SHVFSSKKPMLPAKF | 451 | Q14190 | |
| HKFAEEDLKPQPMIK | 206 | Q10587 | |
| NPKFHMPEDVREKKE | 81 | Q7L1S5 | |
| ERIHKKMLKPAFIFD | 426 | O60701 | |
| LHKMKKAAIDPSAPA | 1216 | Q9C0A1 | |
| DSPPSKKKRMDHVDF | 1221 | Q96T58 | |
| HCKPAKPLPKEMEEF | 281 | P06133 | |
| MFDHFCKKEPKPEPL | 196 | Q92610 | |
| MSKAHPPELKKFTDK | 1 | A8MWD9 | |
| EVDLHFMKKIPPGAE | 316 | Q6U841 | |
| KFPLPMEVFKDHADL | 281 | Q5VUG0 | |
| HCKPAKPLPKEMEEF | 281 | O75310 | |
| FKIEEPHEAKPDKMA | 366 | P11137 | |
| MKVEKDHLAKPFFPA | 386 | A8K0R7 | |
| LKVFKHTLPPKVFEM | 111 | Q6UXN7 | |
| MKLKKPVAFSDYIHP | 466 | P00734 | |
| HCKPAKPLPKEMEEF | 281 | Q9BY64 | |
| LNHKRGPFMPDFKKE | 56 | Q3SY77 | |
| HCKPAKPLPKEMEDF | 281 | P16662 | |
| LPKFDKDHDVMLFLK | 676 | Q93009 | |
| KMFFLFPDPHFKRTK | 156 | Q9UBP6 | |
| IKPNEFKKPMLFDRH | 636 | Q13402 |